Colin J. Meyer
2018
In 2018, Colin J. Meyer earned a total compensation of $625.5K as Chief Medical Officer at REATA PHARMACEUTICALS, a 70% decrease compared to previous year.
Compensation breakdown
| Bonus | $208,500 |
|---|---|
| Salary | $417,000 |
| Total | $625,500 |
Meyer received $417K in salary, accounting for 67% of the total pay in 2018.
Meyer also received $208.5K in bonus.
Rankings
In 2018, Colin J. Meyer's compensation ranked 11,132nd out of 14,244 executives tracked by ExecPay. In other words, Meyer earned more than 21.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,132 out of 14,244 | 22nd |
Division Manufacturing | 4,497 out of 5,765 | 22nd |
Major group Chemicals And Allied Products | 1,705 out of 2,128 | 20th |
Industry group Drugs | 1,445 out of 1,817 | 21st |
Industry Pharmaceutical Preparations | 1,108 out of 1,391 | 20th |
Source: SEC filing on April 30, 2019.
Meyer's colleagues
We found two more compensation records of executives who worked with Colin J. Meyer at REATA PHARMACEUTICALS in 2018.
News
REATA PHARMACEUTICALS CEO J Huff's 2021 pay falls 37% to $4M
April 29, 2022
REATA PHARMACEUTICALS CEO J Huff's 2020 pay rises 15% to $6.4M
April 30, 2021
REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
April 29, 2020
REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
April 30, 2019